Ally Bridge Invests In Two European Biopharmaceutical Firms
February 23, 2017 — 10:10 CST
This Data Is Locked!
This area is available only to Subscribers.
Hong Kong-based cross-border healthcare investment firm Ally Bridge Group has completed investments in two European biopharmaceutical companies, Galenica AG of Switzerland and Nabriva of Austria... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals